Mirae Asset Global ETFs Holdings
CGEM icon

Mirae Asset Global ETFs Holdings’s Cullinan Oncology CGEM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Buy
30,151
+1,492
+5% +$19.2K ﹤0.01% 1967
2025
Q4 		$295K Buy
28,659
+2,671
+10% +$24.1K ﹤0.01% 2162
2025
Q3 		$154K Sell
25,988
-3,866
-13% -$28.3K ﹤0.01% 2461
2025
Q2 		$225K Sell
29,854
-3,465
-10% -$27.8K ﹤0.01% 2216
2025
Q1 		$253K Buy
33,319
+336
+1% +$3.22K ﹤0.01% 2195
2024
Q4 		$402K Buy
32,983
+173
+0.5% +$2.49K ﹤0.01% 2031
2024
Q3 		$551K Buy
32,810
+15,854
+94% +$281K ﹤0.01% 1869
2024
Q2 		$294K Buy
+16,956
New +$361K ﹤0.01% 2079

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return